top of page
  • Writer's pictureRetina & Eye

Spotlight on Dr. Carl D. Regillo: A Leading Light in Ophthalmology at Vail Retina & Eye CME 2024

As we gear up for the Vail Retina & Eye CME 2024, it's our privilege to introduce one of the luminaries in the field of ophthalmology who will be gracing our conference – Dr. Carl D. Regillo, a renowned expert in retinal diseases.

A Journey Marked by Excellence: Dr. Carl D. Regillo's career is a testament to his dedication and expertise in ophthalmology. Currently leading the Retina Service at Wills Eye Hospital and serving as a Professor at Thomas Jefferson University School of Medicine, Dr. Regillo has carved a niche for himself as a top authority on retinal diseases.

Educational Foundation: A valedictorian graduate from Northeastern University's College of Pharmacy and a Phi Kappa Phi honoree, Dr. Regillo's educational journey is impressive. He graduated from Harvard Medical School on a full military scholarship, completed his internship at Brigham and Women’s Hospital, and underwent residency and vitreoretinal fellowship at Wills Eye Hospital, where he was named Co-Chief Resident.

Professional Achievements: Dr. Regillo served in the U.S. Air Force and was a vitreoretinal surgeon at the San Diego Naval Medical Center. His accolades include a Naval Commendation Medal and a teaching award. At Mid Atlantic Retina and Wills Eye Hospital, he became the Director of the Clinical Retina Research Unit and chaired various committees, significantly contributing to the field of ophthalmology.

A Prolific Contributor and Educator: Authoring over 300 scientific papers and 9 major textbooks, Dr. Regillo is a prolific contributor to ophthalmology literature. He holds editorial roles in several distinguished journals and is a fellow of the American College of Surgeons. His participation in prestigious societies and receipt of numerous accolades, including being named one of the top 100 most influential people in ophthalmology, underscores his impact.

Advancing Retinal Care: Dr. Regillo's commitment to advancing retinal care is evident in his leadership of international clinical trials focusing on macular degeneration, diabetic retinopathy, and other retinal conditions.

Conclusion: At the Vail Retina & Eye CME 2024, attendees will have the unique opportunity to learn from and interact with Dr. Regillo, whose contributions to ophthalmology have been both profound and inspiring. Don’t miss out on this chance to gain insights from one of the top minds in the field.

4 views0 comments


bottom of page